Pneumocystis Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumocystis Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients [Phase 2]
Phase 2 trial update for WR 6026 in Pneumocystis jirovecii pneumonia (PCP) among HIV-infected patients has been completed.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients [Phase 3]
Phase 3 clinical trial evaluating the effect of steroids during Pneumocystis infection in non-HIV immunocompromised patients.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria [Phase 4]
Phase 4 trial assessing the impact of cotrimoxazole use in immunocompetent HIV patients on carriage of antimicrobial-resistant bacteria.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP [Phase 4]
A Phase 4 trial update evaluating trimethoprim/sulfamethoxazole combined with caspofungin as first-line therapy for Pneumocystis pneumonia.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Antiretroviral Drug Interaction Study in Volunteers With HIV [Phase 1]
Phase 1 trial evaluating interactions between antiretroviral drugs in volunteers with HIV; study has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-09-28FDA Approved: PENTAMIDINE ISETHIONATE — Original Application (Seton Pharmaceuticals)
FDA approved pentamidine isethionate from Seton Pharmaceuticals through an original ANDA application.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome [Phase 4]
Phase 4 study assessing whether genetic screening for HLA-B*1301 can predict susceptibility to dapsone hypersensitivity syndrome.
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)
NHLBI-sponsored pediatric study on pulmonary and cardiovascular complications of vertically transmitted HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating trimethoprim/sulfamethoxazole for Pneumocystis pneumonia prophylaxis in patients with connective ti…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients [Phase 2]
A Phase II randomized, double-blind trial comparing 566C80 to Septra (sulfamethoxazole/trimethoprim) for Pneumocystis pneumonia in HIV/AIDS …
-
CLINICAL_TRIALS trial_result · 2008-09-30Clinical Trial Update: A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies [Phase 3]
A Phase 3 trial update describes the use of trimetrexate with leucovorin rescue for AIDS patients with Pneumocystis pneumonia who have serio…
-
CLINICAL_TRIALS trial_result · 2008-08-04Clinical Trial Update: A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection
This clinical trial compares HIV-infected patients with and without AIDS-related opportunistic infections, examining outcomes related to cyt…